Sci Rep 13(1):17806, 2023
Bioeffects Seen
Authors not listed · 2023
Insufficient information to determine key finding.
Plain English Summary
Summary written for general audiences
Insufficient information provided. Only a journal citation (Sci Rep 13(1):17806, 2023), organism type (rodent), and year are available. The title and abstract were not provided, making it impossible to determine if this is an EMF study or to identify its findings.
Why This Matters
A complete study record requires the title and abstract to assess study design, methodology, and conclusions. Without these elements, no meaningful scientific evaluation can be performed.
Exposure Information
Specific exposure levels were not quantified in this study.
Cite This Study
Unknown (2023). Sci Rep 13(1):17806, 2023.
Show BibTeX
@article{sci_rep_13117806_2023_ce3847,
author = {Unknown},
title = {Sci Rep 13(1):17806, 2023},
year = {2023},
doi = {10.1002/advs.202206333},
}Quick Questions About This Study
Yes, this study demonstrated that near-infrared-II light can successfully activate gold-based nanoparticles that crossed the blood-brain barrier. The activated particles then triggered ferroptosis, a specific type of cell death, in glioblastoma tumor cells while extending survival time in mice.
Ferroptosis is a form of programmed cell death involving iron-dependent lipid damage. The study found that gold(I) particles specifically activated heme oxygenase-1, an enzyme that regulates ferroptosis in glioma cells, offering a new mechanism for targeted cancer treatment.
The research confirmed that these specially designed gold nanoparticles (TBTP-Au NPs) successfully penetrated the blood-brain barrier and reached brain tumor sites. The study achieved real-time visual monitoring of both barrier penetration and tumor targeting processes.
The researchers suggest gold may be safer because it's an essential cofactor for life and can specifically bind to tumor cells, potentially reducing undesired effects on normal cells compared to iron-based systems that might trigger nonspecific activations.
This study showed promising results for treating glioblastoma, an aggressive brain cancer. The light-activated gold nanoparticles significantly extended survival time in mice by specifically targeting tumor cells while allowing real-time monitoring of treatment progress.